Position in AGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$159,155
-$237,576 QoQ
Shares Held
52,012
-56.2% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 103 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. AGEN ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in AGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $159,155 | 52,012 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $396,731 | 118,782 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $41,590 | 13,246 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,421,857 | 369,314 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,922,496 | 420,678 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $302,528 | 200,351 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $293,515 | 107,123 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $438,211 | 79,966 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $343,273 | 20,494 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $776,414 | 1,338,647 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,110,225 | 1,337,623 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,856,434 | 1,642,864 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,445,335 | 903,336 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,107,231 | 7,965,277 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,949,600 | 1,229,001 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,463,363 | 1,689,447 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $255,444 | 131,674 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $179,032 | 72,778 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $442,570 | 137,445 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $654,768 | 124,718 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,315,648 | 239,645 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $155,081 | 57,016 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $89,663 | 28,197 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $134,336 | 33,585 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $165,140 | 42,021 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,043,369 | 1,242,191 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||